Widman Fredrik
VP Corporate Controller
In the last 12 months, Widman Fredrik filed 51 SEC Form 4 transactions across 1 issuer: $0 in open-market purchases and $3.6M in open-market sales. 57% of these transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.
- $0Open-market buys (1y)
- $3.6MOpen-market sells (1y)
- 51Transactions filed
- 1Distinct issuers
- 57%Under Rule 10b5-1
- 2026-10-23Latest filing
Issuers Filed For By open-market buy volume
Recent Form 4 Filings Most recent 51 of 51 (1-year window)
| Date | Ticker | Company | Type | SEC Code | Value | Shares | Price |
|---|---|---|---|---|---|---|---|
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $93.5K | 307 | $304.7 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $70.4K | 307 | $229.4 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $90.6K | 312 | $290.3 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $141.1K | 406 | $347.4 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $99.7K | 406 | $245.6 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $137.4K | 567 | $242.3 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $100.9K | 567 | $178.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $43.7K | 262 | $166.6 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $48.1K | 263 | $182.8 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $56.6K | 325 | $174.3 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $45.3K | 325 | $139.5 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 325 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 262 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 325 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 567 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 263 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 307 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 567 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 406 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 312 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 307 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 406 | $0.0 |
| 2026-10-23 | ISRG | INTUITIVE SURGICAL INC | Sell 10b5-1 | S | $1.8M | 4,047 | $453.2 |
| 2026-09-15 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $43.5K | 546 | $79.6 |
| 2026-09-15 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $59.5K | 543 | $109.5 |
| 2026-09-15 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 546 | $0.0 |
| 2026-09-15 | ISRG | INTUITIVE SURGICAL INC | Exercise 10b5-1 | M | $0 | 543 | $0.0 |
| 2026-09-15 | ISRG | INTUITIVE SURGICAL INC | Sell 10b5-1 | S | $204.4K | 546 | $374.4 |
| 2026-09-15 | ISRG | INTUITIVE SURGICAL INC | Sell 10b5-1 | S | $203.3K | 543 | $374.4 |
| 2026-03-03 | ISRG | INTUITIVE SURGICAL INC | Sell | – | $57.5K | 118 | $487.2 |
| 2026-02-28 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 468 | $0.0 |
| 2026-02-28 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $117.3K | 233 | $503.5 |
| 2026-02-28 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 468 | $0.0 |
| 2026-02-27 | ISRG | INTUITIVE SURGICAL INC | Sell | – | $124.4K | 249 | $499.7 |
| 2026-02-26 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 611 | $0.0 |
| 2026-02-26 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $153.4K | 303 | $506.2 |
| 2026-02-26 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 378 | $0.0 |
| 2026-02-26 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $95.2K | 188 | $506.2 |
| 2026-02-26 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 611 | $0.0 |
| 2026-02-26 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 378 | $0.0 |
| 2026-02-26 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 1,627 | $0.0 |
| 2026-02-11 | ISRG | INTUITIVE SURGICAL INC | Sell | – | $65.8K | 133 | $495.0 |
| 2026-02-10 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 567 | $0.0 |
| 2026-02-10 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $148.8K | 302 | $492.8 |
| 2026-02-10 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 567 | $0.0 |
| 2025-11-05 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $146.9K | 1,908 | $77.0 |
| 2025-11-05 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $9.5K | 159 | $59.5 |
| 2025-11-05 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 159 | $0.0 |
| 2025-11-05 | ISRG | INTUITIVE SURGICAL INC | Grant | – | $0 | 1,908 | $0.0 |
| 2025-11-05 | ISRG | INTUITIVE SURGICAL INC | Sell | – | $1.0M | 1,908 | $550.0 |
| 2025-11-05 | ISRG | INTUITIVE SURGICAL INC | Sell | – | $87.5K | 159 | $550.0 |
Methodology & FAQ
How These Filings Are Sourced
All transactions on this page are sourced directly from SEC EDGAR. A complete description of the open-market vs grant distinction, the Rule 10b5-1 plan-reference heuristic, and the per-insider name matching is documented in the Methodology.
What companies does Widman Fredrik file Form 4 disclosures for?
Widman Fredrik has filed SEC Form 4 transactions for 1 issuer in the last 12 months: INTUITIVE SURGICAL INC (ISRG).
What does the 10b5-1 badge mean on these transactions?
Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Of Widman Fredrik's 51 reported transactions in the last 12 months, 29 (57%) reference a 10b5-1 trading plan in the Form 4 footnotes.
Are these all the transactions Widman Fredrik has executed?
This page shows SEC Form 4 transactions on record in Pactolio's tracked universe for the last 12 months. Form 4 only covers transactions in registered classes of equity at issuers where the person qualifies as an insider (officer, director, or 10% beneficial owner). Trades in funds, foreign issuers, or non-insider positions are not disclosed under Form 4 and are not included here.